A Type VI Secretion System Encoding Locus Is Required for Bordetella bronchiseptica Immunomodulation and Persistence In Vivo

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Weyrich, Laura S ^a   Rolin, Olivier Y ^a   Muse, Sarah J ^a   Park, Jihye ^a   Spidale, Nicholas ^a   Kennett, Mary J ^a   Hester, Sara E ^a   Chen, Chun ^a   Dudley, Edward G ^a   Harvill, Eric T ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BORDETELLA BRONCHISEPTICA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; GENE DISRUPTION; GENE INDUCTION; GENE LOCUS; IMMUNE RESPONSE; IMMUNOMODULATION; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; TH1 CELL; TYPE VI SECRETION SYSTEM;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BACTERIAL PROTEINS; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; IMMUNOMODULATION; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES; MICE; MULTIGENE FAMILY; UP-REGULATION; VIRULENCE; VIRULENCE FACTORS;

EID: 84867428041     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045892     Document Type: Article

References (88)

1. Boyer F, Fichant G, Berthod J, Vandenbrouck Y, Attree I, (2009) Dissecting the bacterial type VI secretion system by a genome wide in silico analysis: what can be learned from available microbial genomic resources? BMC Genomics 10: 104.
2. Boyd EF, Cohen A, Naughton L, Ussery D, Binnewies T, et al. (2008) Molecular analysis of the emergence of pandemic Vibrio parahaemolyticus. BMC Microbiology 8: 110.
3. Filloux A, Hachani A, Bleves S, (2008) The bacterial type VI secretion machine: yet another player for protein transport across membranes. Microbiology 154: 1570-1583 doi:10.1099/mic.0.2008/016840-0.
4. Cascales E, (2008) The type VI secretion toolkit. EMBO Rep 9: 735-41 doi:10.1038/embor.2008.131.
5. Russell AB, Hood RD, Bui NK, LeRoux M, Vollmer W, et al. (2011) Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475: 343-347 doi:10.1038/nature10244.
6. Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, et al. (2006) Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proceedings of the National Academy of Sciences of the United States of America 103: 1528-1533 doi:10.1073/pnas.0510322103.
7. Suarez G, Sierra JC, Sha J, Wang S, Erova TE, et al. (2008) Molecular characterization of a functional type VI secretion system from a clinical isolate of Aeromonas hydrophila. Microbial Pathogenesis 44: 344-361.
8. Purcell M, Shuman HA, (1998) The Legionella pneumophila icmGCDJBF Genes Are Required for Killing of Human Macrophages. Infect Immun 66: 2245-2255.
9. Schlieker C, Zentgraf H, Dersch P, Mogk A, (2005) ClpV, a unique Hsp100/Clp member of pathogenic proteobacteria. Biological Chemistry 386: 1115-1127 doi:10.1515/BC.2005.128.
10. Suarez G, Sierra JC, Erova TE, Sha J, Horneman AJ, et al. (2010) A Type VI Secretion System Effector Protein, VgrG1, from Aeromonas hydrophila That Induces Host Cell Toxicity by ADP Ribosylation of Actin. J Bacteriol 192: 155-168 doi:10.1128/JB.01260-09.
11. Wang J, Li C, Yang H, Mushegian A, Jin S, (1998) A novel serine/threonine protein kinase homologue of Pseudomonas aeruginosa is specifically inducible within the host infection site and is required for full virulence in neutropenic mice. J Bacteriol 180: 6764-6768.
12. Ma AT, Mekalanos JJ, (2010) In vivo actin cross-linking induced by Vibrio cholerae type VI secretion system is associated with intestinal inflammation. Proc Natl Acad Sci U S A 107: 4365-4370 doi:10.1073/pnas.0915156107.
13. Zheng J, Shin OS, Cameron DE, Mekalanos JJ, (2010) Quorum sensing and a global regulator TsrA control expression of type VI secretion and virulence in Vibrio cholerae. Proceedings of the National Academy of Sciences 107: 21128-21133 doi:10.1073/pnas.1014998107.
14. Schell MA, Ulrich RL, Ribot WJ, Brueggemann EE, Hines HB, et al. (2007) Type VI secretion is a major virulence determinant in Burkholderia mallei. Molecular Microbiology 64: 1466-1485 doi:10.1111/j.1365-2958.2007.05734.x.
15. Dudley EG, Thomson NR, Parkhill J, Morin NP, Nataro JP, (2006) Proteomic and microarray characterization of the AggR regulon identifies a pheU pathogenicity island in enteroaggregative Escherichia coli. Molecular Microbiology 61: 1267-1282.
16. Parsons DA, Heffron F, (2005) sciS, an icmF Homolog in Salmonella enterica Serovar Typhimurium, Limits Intracellular Replication and Decreases Virulence. Infect Immun 73: 4338-4345.
17. Broms JE, Lavander M, Sjostedt A, (2009) A Conserved {alpha}-Helix Essential for a Type VI Secretion-Like System of Francisella tularensis. J Bacteriol 191: 2431-2446 doi:10.1128/jb.01759-08.
18. Mattoo S, Cherry JD, (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18: 326-82.
19. Goodnow RA, (1980) Biology of Bordetella bronchiseptica. Microbiol Rev 44: 722-38.
20. Harvill ET, Cotter PA, Yuk MH, Miller JF, (1999) Probing the function of Bordetella bronchiseptica adenylate cyclase toxin by manipulating host immunity. Infect Immun 67: 1493-500.
21. Shrivastava R, Miller JF, (2009) Virulence factor secretion and translocation by Bordetella species. Current Opinion in Microbiology 12: 88-93.
22. Mazar J, Cotter PA, (2006) Topology and maturation of filamentous haemagglutinin suggest a new model for two-partner secretion. Mol Microbiol 62: 641-54.
23. Finn TM, Stevens LA, (1995) Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant. Molecular Microbiology 16: 625-634 doi:10.1111/j.1365-2958.1995.tb02425.x.
24. Yuk MH, Harvill ET, Cotter PA, Miller JF, (2000) Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system. Mol Microbiol 35: 991-1004.
25. Hickey FB, Brereton CF, Mills KHG, (2008) Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells. J Leukoc Biol 84: 234-243 doi:10.1189/jlb.0208113.
26. Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON, Harvill ET, (2005) Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest 115: 3594-601.
27. Glaser P, Sakamoto H, Bellalou J, Ullmann A, Danchin A, (1988) Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclase-haemolysin bifunctional protein of Bordetella pertussis. Embo J 7: 3997-4004.
28. Hodak H, Clantin B, Willery E, Villeret V, Locht C, et al. (2006) Secretion signal of the filamentous haemagglutinin, a model two-partner secretion substrate. Mol Microbiol 61: 368-382 doi:10.1111/j.1365-2958.2006.05242.x.
29. Weiss AA, Johnson FD, Burns DL, (1993) Molecular characterization of an operon required for pertussis toxin secretion. Proc Natl Acad Sci U S A 90: 2970-4.
30. Skinner JA, Pilione MR, Shen H, Harvill ET, Yuk MH, (2005) Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence. J Immunol 175: 4647-52.
31. Stockbauer KE, Foreman-Wykert AK, Miller JF, (2003) Bordetella type III secretion induces caspase 1-independent necrosis. Cell Microbiol 5: 123-132.
32. Medhekar B, Shrivastava R, Mattoo S, Gingery M, Miller JF, (2009) Bordetella Bsp22 forms a filamentous type III secretion system tip complex and is immunoprotective in vitro and in vivo. Molecular Microbiology 71: 492-504 doi:10.1111/j.1365-2958.2008.06543.x.
33. Panina EM, Mattoo S, Griffith N, Kozak NA, Yuk MH, et al. (2005) A genome-wide screen identifies a Bordetella type III secretion effector and candidate effectors in other species. Mol Microbiol 58: 267-79.
34. Yuk MH, Harvill ET, Miller JF, (1998) The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol Microbiol 28: 945-59.
35. Buboltz AM, Nicholson TL, Weyrich LS, Harvill ET, (2009) Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infect. Immun 77: 3969-3977 doi:10.1128/IAI.01362-08.
36. Bingle LEH, Bailey CM, Pallen MJ, (2008) Type VI secretion: a beginner's guide. Current Opinion in Microbiology 11: 3-8.
37. Cotter PA, Miller JF, (1994) BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect Immun 62: 3381-90.
38. Stainer DW, Scholte MJ, (1970) A simple chemically defined medium for the production of phase I Bordetellla pertussis. J Gen Microbiol 63: 211-220.
39. Buboltz AM, Nicholson TL, Parette MR, Hester SE, Parkhill J, et al. (2008) Replacement of Adenylate Cyclase Toxin in a Lineage of Bordetella bronchiseptica. J Bacteriol pp. JB.00226-08 doi:10.1128/jb.00226-08.
40. Nicholson TL, (2007) Construction and validation of a first-generation Bordetella bronchiseptica long-oligonulceotide microarray by transcriptional profiling the Bvg regulon. BMC Genomics 8: 220.
41. Saeed AI, Sharov V, White J, Li J, Liang W, et al. (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-8.
42. Mattoo S, Yuk MH, Huang LL, Miller JF, (2004) Regulation of type III secretion in Bordetella. Mol Microbiol 52: 1201-14.
43. Dupont A, Tokarski C, Dekeyzer O, Guihot A-L, Amouyel P, et al. (2004) Two-dimensional maps and databases of the human macrophage proteome and secretome. Proteomics 4: 1761-1778 doi:10.1002/pmic.200300691.
44. Manna D, Aligo J, Xu C, Park WS, Koc H, et al. (n.d.) Endocytic Rab proteins are required for hepatitis C virus replication complex formation. Virology 398: 21-37.
45. Mann PB, Kennett MJ, Harvill ET, (2004) Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J Infect Dis 189: 833-6.
46. Zhang X, Hester SE, Kennett MJ, Karanikas AT, Bendor L, et al. (2011) Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis. Infect Immun 79: 527-541 doi:10.1128/IAI.00590-10.
47. Kirimanjeswara GS, Mann PB, Harvill ET, (2003) Role of antibodies in immunity to Bordetella infections. Infect Immun 71: 1719-24.
48. Mann PB, Elder KD, Kennett MJ, Harvill ET, (2004) Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica. Infect Immun 72: 6650-8.
49. Shalom G, Shaw JG, Thomas MS, (2007) In vivo expression technology identifies a type VI secretion system locus in Burkholderia pseudomallei that is induced upon invasion of macrophages. Microbiology 153: 2689-2699 doi:10.1099/mic.0.2007/006585-0.
50. Hanson PI, Whiteheart SW, (2005) AAA+ proteins: have engine, will work. Nat Rev Mol Cell Biol 6: 519-529 doi:10.1038/nrm1684.
51. Bönemann G, Pietrosiuk A, Diemand A, Zentgraf H, Mogk A, (2009) Remodelling of VipA/VipB tubules by ClpV-mediated threading is crucial for type VI protein secretion. EMBO J 28: 315-325 doi:10.1038/emboj.2008.269.
52. Zheng J, Ho B, Mekalanos JJ, (2011) Genetic Analysis of Anti-Amoebae and Anti-Bacterial Activities of the Type VI Secretion System in Vibrio cholerae. PLoS ONE 6: e23876 doi:10.1371/journal.pone.0023876.
53. Basler M, Pilhofer M, Henderson GP, Jensen GJ, Mekalanos JJ, (2012) Type VI secretion requires a dynamic contractile phage tail-like structure. Nature 483: 182-186 doi:10.1038/nature10846.
54. Zheng J, Leung KY, (2007) Dissection of a type VI secretion system in Edwardsiella tarda. Molecular Microbiology 66: 1192-1206 doi:10.1111/j.1365-2958.2007.05993.x.
55. Filloux A, (2009) The type VI secretion system: a tubular story. EMBO J 28: 309-310.
56. Sheahan K-L, Cordero CL, Fullner Satchell KJ, (2004) Identification of a domain within the multifunctional Vibrio cholerae RTX toxin that covalently cross-links actin. Proceedings of the National Academy of Sciences of the United States of America 101: 9798-9803 doi:10.1073/pnas.0401104101.
57. Pukatzki S, McAuley SB, Miyata ST, (2009) The type VI secretion system: translocation of effectors and effector-domains. Current Opinion in Microbiology 12: 11-17.
58. Hood RD, Singh P, Hsu F, Güvener T, Carl MA, et al. (2010) A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe 7: 25-37 doi:10.1016/j.chom.2009.12.007.
59. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, et al. (2005) Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog 1: e45.
60. Mougous JD, Cuff ME, Raunser S, Shen A, Zhou M, et al. (2006) A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science 312: 1526-1530 doi:10.1126/science.1128393.
61. Heininger U, Cotter PA, Fescemyer HW, Martinez de Tejada G, Yuk MH, et al. (2002) Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun 70: 3777-84.
62. Mann P, Goebel E, Barbarich J, Pilione M, Kennett M, et al. (2007) Use of a Genetically Defined Double Mutant Strain of Bordetella bronchiseptica Lacking Adenylate Cyclase and Type III Secretion as a Live Vaccine. Infect Immun 75: 3665-72.
63. Kirimanjeswara GS, Mann PB, Harvill ET, (2003) Role of Antibodies in Immunity to Bordetella Infections. Infect Immun 71: 1719-1724 doi:10.1128/iai.71.4.1719-1724.2003.
64. Pishko EJ, Kirimanjeswara GS, Pilione MR, Gopinathan L, Kennett MJ, et al. (2004) Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3. Eur J Immunol 34: 184-93.
65. Andreasen C, Powell DA, Carbonetti NH, (2009) Pertussis Toxin Stimulates IL-17 Production in Response to Bordetella pertussis Infection in Mice. PLoS ONE 4: e7079 doi:10.1371/journal.pone.0007079.
66. Schlieker C, Zentgraf H, Dersch P, Mogk A, (2005) ClpV, a unique Hsp100/Clp member of pathogenic proteobacteria. Biological Chemistry 386: 1115-1127 doi:doi: 10.1515/BC.2005.128.
67. Williams JM, Chen G, Zhu L, Rest RF, (1998) Using the yeast two-hybrid system to identify human epithelial cell proteins that bind gonococcal Opa proteins: intracellular gonococci bind pyruvate kinase via their Opa proteins and require host pyruvate for growth. Molecular Microbiology 27: 171-186 doi:10.1046/j.1365-2958.1998.00670.x.
68. Shoshan-Barmatz V, Israelson A, Brdiczka D, Sheu SS, (2006) The Voltage-Dependent Anion Channel (VDAC): Function in Intracellular Signalling, Cell Life and Cell Death. Current Pharmaceutical Design 12: 2249-2270 doi:10.2174/138161206777585111.
69. Stebbins CE, Galán JE, (2001) Structural mimicry in bacterial virulence. Nature 412: 701-705 doi:10.1038/35089000.
70. Li J, Ran C, Li E, Gordon F, Comstock G, et al. (2008) Synergistic Function of E2F7 and E2F8 Is Essential for Cell Survival and Embryonic Development. Developmental Cell 14: 62-75 doi:10.1016/j.devcel.2007.10.017.
71. Kim SY, Lee SM, Tak JK, Choi KS, Kwon TK, et al. (2007) Regulation of singlet oxygen-induced apoptosis by cytosolic NADP+-dependent isocitrate dehydrogenase. Molecular and Cellular Biochemistry 302: 27-34 doi:10.1007/s11010-007-9421-x.
72. Lang F, Lang PA, Lang KS, Brand V, Tanneur V, et al. (2004) Channel-induced apoptosis of infected host cells?the case of malaria. Pflugers Archiv European Journal of Physiology 448: 319-324 doi:10.1007/s00424-004-1254-9.
73. Rosales-Reyes R, Skeldon AM, Aubert DF, Valvano MA, (2012) The Type VI secretion system of Burkholderia cenocepacia targets multiple Rho family GTPases disrupting the actin cytoskeleton and the assembly of NADPH oxidase complex in macrophages. Cellular Microbiology 14: 255-73 doi:10.1111/j.1462-5822.2011.01716.x.
74. Brandt U, (2006) Energy Converting NADH: Quinone Oxidoreductase (Complex I). Annual Review of Biochemistry 75: 69-92 doi:10.1146/annurev.biochem.75.103004.142539.
75. Steuber J, Schmid C, Rufibach M, Dimroth P, (2000) Na+ translocation by complex I (NADH:quinone oxidoreductase) of Escherichia coli. Molecular Microbiology 35: 428-434 doi:10.1046/j.1365-2958.2000.01712.x.
76. Yagi T, (1991) Bacterial NADH-quinone oxidoreductases. Journal of Bioenergetics and Biomembranes 23: 211-225 doi:10.1007/BF00762218.
77. Wang G, Maier RJ, (2004) An NADPH Quinone Reductase of Helicobacter pylori Plays an Important Role in Oxidative Stress Resistance and Host Colonization. Infect Immun 72: 1391-1396 doi:10.1128/IAI.72.3.1391-1396.2004.
78. Petrussa E, Bertolini A, Casolo V, Krajňáková J, Macrì F, et al. (2009) Mitochondrial bioenergetics linked to the manifestation of programmed cell death during somatic embryogenesis of Abies alba. Planta 231: 93-107 doi:10.1007/s00425-009-1028-x.
79. Chomova M, Racay P, (2010) Mitochondrial complex I in the network of known and unknown facts. General Physiology and Biophysics 29: 3-11 doi:10.4149/gpb_2010_01_3.
80. Pilione MR, Harvill ET, (2006) The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infect Immun 74: 1043-9.
81. Kirimanjeswara GS, Mann PB, Pilione M, Kennett MJ, Harvill ET, (2005) The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4. J Immunol 175: 7504-11.
82. Cotter PA, Yuk MH, Mattoo S, Akerley BJ, Boschwitz J, et al. (1998) Filamentous hemagglutinin of Bordetella bronchiseptica is required for efficient establishment of tracheal colonization. Infect Immun 66: 5921-9.
83. Murdoch SL, Trunk K, English G, Fritsch MJ, Pourkarimi E, et al. (2011) The Opportunistic Pathogen Serratia marcescens Utilizes Type VI Secretion To Target Bacterial Competitors. J Bacteriol 193: 6057-6069 doi:10.1128/JB.05671-11.
84. Stockbauer KE, Foreman-Wykert AK, Miller JF, (2003) Bordetella type III secretion induces caspase 1-independent necrosis. Cellular Microbiology 5: 123-132 doi:doi:10.1046/j.1462-5822.2003.00260.x.
85. Fennelly NK, Sisti F, Higgins SC, Ross PJ, van der Heide H, et al. (2008) Bordetella pertussis Expresses a Functional Type III Secretion System That Subverts Protective Innate and Adaptive Immune Responses. Infect Immun 76: 1257-1266 doi:10.1128/iai.00836-07.
86. French CT, Panina EM, Yeh SH, Griffith N, Arambula DG, et al. (2009) The Bordetella T3SS effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts. Cell Microbiol 11: 1735-1749 doi:10.1111/j.1462-5822.2009.01361.x.
87. Ming Huam Y, Eric TH, Peggy AC, Jeff FM, (2000) Modulation of host immune responses, induction of apoptosis and inhibition of NF-κB activation by the Bordetella type III secretion system. Molecular Microbiology 35: 991-1004.
88. Ma AT, Mekalanos JJ, (2010) In vivo actin cross-linking induced by Vibrio cholerae type VI secretion system is associated with intestinal inflammation. Proceedings of the National Academy of Sciences 107: 4365-4370 doi:10.1073/pnas.0915156107.